Before you sell to, join or invest in Inductive Bio, Inc.
MentionFox check on Inductive Bio, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/inductive-bio-inc-form-d-25000001
Check Inductive Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Inductive Bio, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Inductive Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-07.
Inductive Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 7, 2025. The filing reports $25.11M sold. Its industry group is Other Technology. It names Joshua Haimson (Executive Officer, Director), Benjamin Birnbaum (Executive Officer, Director), Rohan Ganesh (Director) (SEC Form D, May 7, 2025).
Is this your company?
Sell to companies like Inductive Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Inductive Bio, Inc.
Free to see. No signup.
More on the people and the money behind Inductive Bio, Inc., from the filings we hold.
Other Technology raises by companies based in New York, filed in May 2025, largest first.
Get an email when Inductive Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Inductive Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Inductive Bio, Inc. →Get the full cited report on Inductive Bio, Inc.
What the filing shows about Inductive Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Inductive Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Inductive Bio, Inc.'s address as 550 Vanderbilt Ave #730, Brooklyn, NY 11238.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Inductive Bio, Inc. is a registered filer with the SEC (CIK 2065009) and has filed since 2025-05-07. 1 filing is on record, the latest on 2025-05-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Inductive Bio, Inc.'s Form D of 2025-05-07 names Joshua Haimson, Benjamin Birnbaum and Rohan Ganesh as its officers, directors or promoters.
Its new offerings report $25.11M sold across 1 offering, as its own filings state.
Trailing twelve months. 3839 filings in Other Technology, totalled by week.
The Issuer will use the proceeds from the sale of the shares for product development and other general corporate purposes, including the payment of salaries and others fees to those listed in Item 3.
Joshua Haimson is named as Executive Officer and Director on the Form D that Inductive Bio, Inc. filed with the SEC on 7 May 2025, one of 3 people that filing names.
Benjamin Birnbaum is named as Executive Officer and Director on the Form D that Inductive Bio, Inc. filed with the SEC on 7 May 2025, one of 3 people that filing names.
Rohan Ganesh is named as Director on the Form D that Inductive Bio, Inc. filed with the SEC on 7 May 2025, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2025-05-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Inductive Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Inductive Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Inductive Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Inductive Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Inductive Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Inductive Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/inductive-bio-inc-form-d-25000001